Literature DB >> 16260763

Crystal structures of T cell receptor (beta) chains related to rheumatoid arthritis.

Hongmin Li1, Sandra Van Vranken, Yiwei Zhao, Zhong Li, Yi Guo, Leslie Eisele, Yixin Li.   

Abstract

The crystal structures of the Vbeta17+ beta chains of two human T cell receptors (TCRs), originally derived from the synovial fluid (SF4) and tissue (C5-1) of a patient with rheumatoid arthritis (RA), have been determined in native (SF4) and mutant (C5-1(F104-->Y/C187-->S)) forms, respectively. These TCR beta chains form homo-dimers in solution and in crystals. Structural comparison reveals that the main-chain conformations in the CDR regions of the C5-1 and SF4 Vbeta17 closely resemble those of a Vbeta17 JM22 in a bound form; however, the CDR3 region shows different conformations among these three Vbeta17 structures. At the side-chain level, conformational differences were observed at the CDR2 regions between our two ligand-free forms and the bound JM22 form. Other significant differences were observed at the Vbeta regions 8-12, 40-44, and 82-88 between C5-1/SF4 and JM22 Vbeta17, implying that there is considerable variability in the structures of very similar beta chains. Structural alignments also reveal a considerable variation in the Vbeta-Cbeta associations, and this may affect ligand recognition. The crystal structures also provide insights into the structure basis of T cell recognition of Mycoplasma arthritidis mitogen (MAM), a superantigen that may be implicated in the development of human RA. Structural comparisons of the Vbeta domains of known TCR structures indicate that there are significant similarities among Vbeta regions that are MAM-reactive, whereas there appear to be significant structural differences among those Vbeta regions that lack MAM-reactivity. It further reveals that CDR2 and framework region (FR) 3 are likely to account for the binding of TCR to MAM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260763      PMCID: PMC2253245          DOI: 10.1110/ps.051748305

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  97 in total

1.  Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions.

Authors:  M Machius; P Cianga; J Deisenhofer; E S Ward
Journal:  J Mol Biol       Date:  2001-07-20       Impact factor: 5.469

2.  A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex.

Authors:  Jean Baptiste Reiser; Claude Grégoire; Claudine Darnault; Thomas Mosser; Annick Guimezanes; Anne Marie Schmitt-Verhulst; Juan Carlos Fontecilla-Camps; Gilbert Mazza; Bernard Malissen; Dominique Housset
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

3.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

4.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.

Authors:  A Dessen; C M Lawrence; S Cupo; D M Zaller; D C Wiley
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

5.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

6.  Evidence of clonotypic pattern of T-cell repertoire in synovial fluid of children with juvenile rheumatoid arthritis at the onset of the disease.

Authors:  L Chini; M Bardare; C Cancrini; F Angelini; L Mancia; E Cortis; A Finocchi; C Riccardi; P Rossi
Journal:  Scand J Immunol       Date:  2002-11       Impact factor: 3.487

7.  Local and transmitted conformational changes on complexation of an anti-sweetener Fab.

Authors:  L W Guddat; L Shan; J M Anchin; D S Linthicum; A B Edmundson
Journal:  J Mol Biol       Date:  1994-02-11       Impact factor: 5.469

8.  Increased frequency of V beta 17-positive T cells in patients with rheumatoid arthritis.

Authors:  G Zagon; J R Tumang; Y Li; S M Friedman; M K Crow
Journal:  Arthritis Rheum       Date:  1994-10

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

10.  A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection.

Authors:  Jennifer Buslepp; Huanchen Wang; William E Biddison; Ettore Appella; Edward J Collins
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

View more
  4 in total

1.  Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC.

Authors:  Limin Wang; Yiwei Zhao; Zhong Li; Yi Guo; Lindsay L Jones; David M Kranz; Walid Mourad; Hongmin Li
Journal:  Nat Struct Mol Biol       Date:  2007-01-14       Impact factor: 15.369

2.  Lipid-derived free radical production in superantigen-induced interstitial pneumonia.

Authors:  Hisako Miyakawa; Ronald P Mason; Jinjie Jiang; Maria B Kadiiska
Journal:  Free Radic Biol Med       Date:  2009-04-17       Impact factor: 7.376

3.  NMR: an essential structural tool for integrative studies of T cell development, pMHC ligand recognition and TCR mechanobiology.

Authors:  Robert J Mallis; Kristine N Brazin; Jonathan S Duke-Cohan; Wonmuk Hwang; Jia-Huai Wang; Gerhard Wagner; Haribabu Arthanari; Matthew J Lang; Ellis L Reinherz
Journal:  J Biomol NMR       Date:  2019-02-27       Impact factor: 2.835

4.  Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells.

Authors:  Hendrik Ziegler; Christian Welker; Marco Sterk; Jan Haarer; Hans-Georg Rammensee; Rupert Handgretinger; Karin Schilbach
Journal:  Front Immunol       Date:  2014-12-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.